Atezolizumab plus Bevacizumab in Patients with Unresectable or Metastatic Mucosal Melanoma: A Multicenter, Open-Label, Single-Arm Phase II Study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.